Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma.

Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma. — المؤلف: Rizell, Magnus — Frontiers in oncology 2019

المؤلف
Rizell, Magnus
النشر
Frontiers in oncology 2019
الوصف
19 p.